Genomics & Informatics

Korea Genome Organization (한국유전체학회)
권호 표지
DOI QR코드

DOI QR Code

COVID-19 progression towards ARDS: a genome wide study reveals host factors underlying critical COVID-19

  • Shama Mujawar (MIT School of Bioengineering Sciences and Research, MIT-Art, Design and Technology University) ;
  • Gayatri Patil (MIT School of Bioengineering Sciences and Research, MIT-Art, Design and Technology University) ;
  • Srushti Suthar (MIT School of Bioengineering Sciences and Research, MIT-Art, Design and Technology University) ;
  • Tanuja Shendkar (MIT School of Bioengineering Sciences and Research, MIT-Art, Design and Technology University) ;
  • Vaishnavi Gangadhar (MIT School of Bioengineering Sciences and Research, MIT-Art, Design and Technology University)
  • Received : 2022.12.27
  • Accepted : 2023.05.22
  • Published : 2023.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Coronavirus disease 2019 (COVID-19) is a viral infection produced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus epidemic, which was declared a global pandemic in March 2020. The World Health Organization has recorded around 43.3 billion cases and 59.4 million casualties to date, posing a severe threat to global health. Severe COVID-19 indicates viral pneumonia caused by the SARS-CoV-2 infections, which can induce fatal consequences, including acute respiratory distress syndrome (ARDS). The purpose of this research is to better understand the COVID-19 and ARDS pathways, as well as to find targeted single nucleotide polymorphism. To accomplish this, we retrieved over 100 patients' samples from the Sequence Read Archive, National Center for Biotechnology Information. These sequences were processed through the Galaxy server next generation sequencing pipeline for variant analysis and then visualized in the Integrative Genomics Viewer, and performed statistical analysis using t-tests and Bonferroni correction, where six major genes were identified as DNAH7, CLUAP1, PPA2, PAPSS1, TLR4, and IFITM3. Furthermore, a complete understanding of the genomes of COVID-19-related ARDS will aid in the early identification and treatment of target proteins. Finally, the discovery of novel therapeutics based on discovered proteins can assist to slow the progression of ARDS and lower fatality rates.

Keywords

Acknowledgement

The authors would like to thank the Director and Head of School, MIT School of Bioengineering Sciences & Research for giving an opportunity to work independently and all there support with the best lab facilities.

References

  1. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020;91:157-160.
  2. World Health Organization. Geneva: World Health Organization, 2022. Accessed 2022 Nov 30. Available from: https://www.who.int/.
  3. Aslan A, Aslan C, Zolbanin NM, Jafari R. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia (Nathan) 2021;13:14.
  4. Tzotzos SJ, Fischer B, Fischer H, Zeitlinger M. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey. Crit Care 2020;24:516.
  5. Li X, Ma X. Acute respiratory failure in COVID-19: is it "typical" ARDS? Crit Care 2020;24:198.
  6. ARDS Definition Task Force; Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526-2533.
  7. Peck TJ, Hibbert KA. Recent advances in the understanding and management of ARDS. F1000Res 2019;8:F1000 Faculty Rev1959.
  8. Menk M, Estenssoro E, Sahetya SK, Neto AS, Sinha P, Slutsky AS, et al. Current and evolving standards of care for patients with ARDS. Intensive Care Med 2020;46:2157-2167. https://doi.org/10.1007/s00134-020-06299-6
  9. Brower RG, Ware LB, Berthiaume Y, Matthay MA. Treatment of ARDS. Chest 2001;120:1347-1367. https://doi.org/10.1378/chest.120.4.1347
  10. Boyle AJ, Mac Sweeney R, McAuley DF. Pharmacological treatments in ARDS: a state-of-the-art update. BMC Med 2013;11:166.
  11. Malin JJ, Suarez I, Priesner V, Fatkenheuer G, Rybniker J. Remdesivir against COVID-19 and other viral diseases. Clin Microbiol Rev 2020;34:e00162-20. 
  12. Wong JJ, Leong JY, Lee JH, Albani S, Yeo JG. Insights into the immuno-pathogenesis of acute respiratory distress syndrome. Ann Transl Med 2019;7:504.
  13. Zheng F, Pan Y, Yang Y, Zeng C, Fang X, Shu Q, et al. Novel biomarkers for acute respiratory distress syndrome: genetics, epigenetics and transcriptomics. Biomark Med 2022;16:217-231. https://doi.org/10.2217/bmm-2021-0749
  14. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020;24:91-98. https://doi.org/10.1016/j.jare.2020.03.005
  15. Chen X, Kang Y, Luo J, Pang K, Xu X, Wu J, et al. Next-generation sequencing reveals the progression of COVID-19. Front Cell Infect Microbiol 2021;11:632490.
  16. Hu J, Li C, Wang S, Li T, Zhang H. Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data. Hum Genomics 2021;15:10.
  17. Upadhyai P, Shenoy PU, Banjan B, Albeshr MF, Mahboob S, Manzoor I, et al. Exome-wide association study reveals host genetic variants likely associated with the severity of COVID-19 in patients of European ancestry. Life (Basel) 2022;12:1300.
  18. Puckelwartz MJ, Pesce LL, Nelakuditi V, Dellefave-Castillo L, Golbus JR, Day SM, et al. Supercomputing for the parallelization of whole genome analysis. Bioinformatics 2014;30:1508-1513. https://doi.org/10.1093/bioinformatics/btu071
  19. Chauhan AJ, Wiffen LJ, Brown TP. COVID-19: a collision of complement, coagulation and inflammatory pathways. J Thromb Haemost 2020;18:2110-2117. https://doi.org/10.1111/jth.14981
  20. Yadav H, Thompson BT, Gajic O. Fifty years of tesearch in ARDS: is acute respiratory distress syndrome a preventable disease? Am J Respir Crit Care Med 2017;195:725-736. https://doi.org/10.1164/rccm.201609-1767CI
  21. National Center for Biotechnology Information. Bethesda: National Center for Biotechnology Information, 2022. Accessed 2022 Dec 15. Available from: https://www.ncbi.nlm.nih.gov/.
  22. SRA - NCBI. Bethesda: National Library of Medicine, 2022. Accessed 2022 Dec 15. Available from: https://www.ncbi.nlm.nih.gov/sra/.
  23. EMBL-EBI. Variant identification and analysis. Variant identification and analysis. Cambridgeshire: EMBL-EBI, 2022. Accessed 2022 Dec 15. Available from: https://www.ebi.ac.uk/training/ online/courses/human-genetic-variation-introduction/variant-identification-and-analysis/.
  24. Galaxy. Galaxy Community, 2022. Accessed 2022 Dec 15. Available from: https://usegalaxy.org/.
  25. Saif R, Ejaz A, Mehmood T, Asif F, Alghanem SM, Ahmad TS. Introduction to galaxy platform for NGS variant calling pipeline. Adv Life Sci 2020;7:129-134.
  26. What is FastQC. Cambridgeshire: Babraham Institute, 2013. Accessed 2022 Dec 15. Available from: https://www.bioinformatics.babraham.ac.uk/projects/fastqc/Help/1%20Introduction/1.1%20What%20is%20FastQC.html.
  27. Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods 2015;12:357-360. https://doi.org/10.1038/nmeth.3317
  28. Robinson JT, Thoraldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol 2011;29:24-26. https://doi.org/10.1038/nbt.1754
  29. Integrative Genomics Viewer. Oakland: Broad Institute and the Regents of the University of California, c2013-2021. Accessed 2022 Dec 15. Available from: https://software.broadinstitute.org/software/igv/.
  30. Bukowski R, Sun Q, Wang M. Variant Calling part 1 (Galaxy) - Bioinformatics Documentation. North Melbourne: Melbourne Bioinformatics, 2022. Accessed 2022 Dec 15. Available from: https://melbournebioinformatics.github.io/MelBioInf_docs/tutorials/var_detect_advanced/var_detect_advanced/.
  31. Introduction. SnpEff & SnpSift Documentation, 2012. Accessed 2022 Dec 15. Available from: http://pcingola.github.io/SnpEff/se_introduction/.
  32. Variant Calling part 2 (Galaxy) - Bioinformatics Documentation. North Melbourne: Melbourne Bioinformatics, 2022. Accessed 2022 Dec 15. Available from: https://melbournebioinformatics.github.io/MelBioInf_docs/tutorials/var_detect_advanced/ var_detect_advanced/.
  33. Zhang Y, Qin L, Zhao Y, Zhang P, Xu B, Li K, et al. Interferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019. J Infect Dis 2020;222:34-37. https://doi.org/10.1093/infdis/jiaa224
  34. Zong Y, Li X. Identification of causal genes of COVID-19 using the SMR method. Front Genet 2021;12:690349.
  35. Aboudounya MM, Heads RJ. COVID-19 and Toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. Mediators Inflamm 2021;2021:8874339.
  36. Ali HN, Niranji SS, Al-Jaf SM. Association of Toll-like receptor-4 polymorphism with SARS CoV-2 infection in Kurdish population. Human Gene 2022;34:201115.